LamdaGen’s Optical Enhancement System™ (OES™) based diagnostic platform allows precise quantification of cTnI in human whole blood, plasma and serum samples.

For optimization of the cTnI assay, the company utilized HyTest’s monoclonal antibodies and troponin I-T-C complex.
For more information, please see the application note below.

Download file:

Application note OES™ Quantification of cTnI in Whole Serum.pdf